Provocative Testing & Coronary Artery Spasms

Provocative Ergonovine Testing Can Rule Out or Confirm the Diagnosis

Artery-690×380

When catheterization reveals normal coronary arteries in a patient complaining of angina, the tendency is to suspect a noncardiac condition. But if the patient continues to have angina, the diagnosis of coronary artery (CA) spasm should be considered.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

CA spasm producing angina in the absence of coronary artery disease (CAD) is a rare condition with certain characteristics that differentiate it from angina caused by ischemia. CA spasm angina predominantly occurs at rest, often awakening the patient at night or in the early morning. These episodes are transient, generally persisting for less than 15 minutes, and may cause syncope. Episodes can occur a few times yearly, a few times daily or infrequently.

The etiology of CA spasm is unknown. Most patients are aged 40 to 60. It is uncommon after age 70. Men and women are affected equally. In women, it may occur with menstruation. It is often associated with spasms in other arteries, causing conditions such as migraine or Reynaud’s syndrome.

Diagnostic dilemmas

Certain changes seen on EKG during an episode of spasm, most often ST elevation, can help make the diagnosis. The elevation generally resolves spontaneously in 10 to 15 minutes or in 1 to 2 minutes with nitroglycerin. Other patients may have ST-segment depression, ventricular tachycardia, ventricular fibrillation, complete heart block or asystole.

A Holter monitor makes it possible to capture some episodes of CA spasm. However, the quixotic nature of these spasms makes EKG documentation difficult to obtain.

Provocative testing

At Cleveland Clinic, we consider provocative ergonovine testing the definitive test for diagnosing this discreet syndrome. We have used it regularly 1972 and have found it to be effective in ruling out or confirming CA spasm. We consider the test safe: In our experience, no patient has died or developed a myocardial infarction during the test.

Advertisement

Ergonovine is a smooth muscle constrictor used primarily to stop postpartum bleeding. When given in the coronaries, ergonovine constricts the smooth muscle cells in the epithelium and triggers angina.

Provocative ergonomine testing is conducted in the cath lab. We first image the coronaries to ensure they are free of obstructive CAD. A bolus of ergonovine is then injected intravenously. Most patients will respond within 5 minutes. We take a complete EKG every minute, as changes in the EKG sometimes appear prior to angina. As soon as angina occurs, we reimage the coronaries. The patient is then given a syringe of premixed nitroglycerine or verapamil to reverse the spasm. The EKG should immediately normalize.

Less effective treatments

Numerous methods of testing for CA spasm have been tried over the years. Hyperventilation can trigger CA spasm, as can putting the patient’s hand in ice water for five minutes—an inhumane test that was popular in the 1970s. Neither was very sensitive, but occasionally worked.

Some institutions conduct provocative testing with acetocholine. However, this agent tends to elicit CA spasm in patients with CAD. We have seen patients who underwent provocative acetocholine testing and were diagnosed with CA spasm. When we repeated the test with ergonomine, the results were negative.

Stress testing is usually not helpful in making a diagnosis, unless the angina occurs with exertion. This scenario is the exception, rather than the rule.

Advertisement

Treating CA spasm

Once CA spasm is confirmed, calcium blockers can be used to control the spasms. A low dose is effective in some patients. Others require larger doses or even multiple calcium blockers.

Related Articles

21-HVI-2541213_chest-pain_650x450
New Guideline Helps Evaluate Risk in Patients With Chest Pain

Further acute testing not needed if ECG and high-sensitivity troponin are negative

20-HVI-1987645-scott-cameron-md-phd_650x450
New Head of Vascular Medicine Looks to Enhance Collaborative Caregiving

Scott Cameron, MD, PhD, also brings wide-ranging research interests to bear

20-HVI-1961369-acute-stroke-in-brain_650x450
Stroke Risk in Cardiac Surgery: New Guidance for Averting a Dreaded Complication

AHA statement is first comprehensive document on perioperative stroke reduction

20-HVI-1898975 Singh_Guidelines on CV imaging in athletes_CQD_650x450_993744768
First Formal Guidance Issued on Multimodality Cardiac Imaging in Young Athletes

Recommendations help distinguish exercise-induced remodeling from pathology

20-HVI-1892867-ablation-roundup-650×450
Trio of Studies at Virtual HRS Meeting Showcase Catheter Ablation Advances

Pushing the envelope in ablation of atrial fibrillation, ventricular tachycardia

Ad